First human test for new DMD drug begins
NCT ID NCT07347548
Summary
This is a very early study to check if a new drug called GRT6019 is safe for people. It will be given to 24 healthy male volunteers for four weeks to see how their bodies react and process it. The main goal is to find the right dose and understand side effects before testing in people with Duchenne Muscular Dystrophy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DUCHENNE MUSCULAR DYSTROPHY (DMD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Biotrial Clinical Pharmacology Unit
RECRUITINGRennes, 35042, France
Contact Phone: •••-•••-••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.